Skip to main content
Premium Trial:

Request an Annual Quote

Synthetic Biology Boost

The UK's Biotechnology and Biological Sciences Research Council has said that it will invest around £20 million ($32 million) in six synthetic biology research projects in the country, which will focus on global challenges such as producing low-carbon fuels and reducing the cost of industrial raw materials.

The financial support will also help build a synthetic biology research community in the UK, the BBSRC says.

The grants are part of BBSRC's Strategic Longer and Larger Awards scheme, which aims to give research teams the time and resources to address areas of key strategic importance. The grants form a network of investment in synthetic biology for the so-called Knowledge Based Bioeconomy.

Douglas Kell, chief executive of the BBSRC, says in a statement that "the funding is a major step in exploring the capacity of synthetic biology to develop useful applications."

Also, "the investment recognizes the important role that synthetic biology can play in addressing many of the grand challenges we face, and in helping to provide future prosperity," he says.

Our sister publication GenomeWeb Daily News has more on the announcement here.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.